MANKIND
MANKIND PHARMA LIMITEDHealthcare
LTP
2,456
CHG · %
+35.7 (+1.48%)
VOL · TODAY
1.68L
PREV CLOSE
2,420.3
Today's range2,415.6 · 2,456
2,456
52-week range1,909.7 · 2,674
2,456
Loading candles…
Mankind Pharma Limited, incorporated in 1995, operates primarily in the pharmaceutical and consumer healthcare industries within India. The company develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products across acute and chronic therapeutic areas. It holds a significant position in the domestic Indian market, ranking fourth by value and second by volume in the Indian pharmaceutical sector. Mankind Pharma has transitioned from a marketing-led business model to a vertically integrated organization with notable manufacturing and research and development capabilities. Its product portfolio includes pharmaceutical formulations, consumer healthcare products, and pregnancy test kits, with more than 80% market share in key categories such as pregnancy test kits. The company does not list any key founders, key management personnel, subsidiaries, or stock exchange listings in the available information.
This page is a live market overview for MANKIND PHARMA LIMITED (MANKIND) on the NSE. As a listed security, MANKIND PHARMA LIMITED is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for MANKIND before placing trades on tick2trade.
As of the latest feed, MANKIND last traded at ₹2,456 on NSE, up ₹35.7 (1.48%) from the previous close of ₹2,420.3. Today's session range is ₹2,415.6 – ₹2,456, against a 52-week band of ₹1,909.7 – ₹2,674. Traded volume today stands at 1.68L shares.
The overview consolidates an interactive price chart with multiple time ranges, a near-the-money option chain snapshot, recent market headlines, upcoming corporate events for MANKIND in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether MANKIND is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for MANKIND PHARMA LIMITED before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in MANKIND. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated MANKIND option chain page linked from this overview.
// similar in healthcare314 total